Selected Publications

  1. O’Sullivan, T., Saddawi-Konefka, R., Tran, M., Mayfield, S.P., Ikeda, H., and Bui, J.D. Interleukin-17D mediates tumor rejection through recruitment of natural killer cells. Cell Reports 2014 Apr 30. pii: S2211-1247(14)00283-6.
  2. Läubli H, Pearce OM, Schwarz F, Siddiqui SS, Deng L, Stanczak MA, Deng L, Verhagen A, Secrest P, Lusk C, Schwartz AG, Varki NM, Bui JD, Varki A. Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer. Proc Natl Acad Sci U S A. 2014 Sep 30;111(39):14211-6.
  3. Saddawi-Konefka R, Seelige R, Gross ET, Levy E, Searles SC, Washington A Jr, Santosa EK, Liu B, O'Sullivan TE, Harismendy O, Bui JD. Nrf2 Induces IL-17D to Mediate Tumor and Virus Surveillance. Cell Rep. 2016 Aug 17.
  4. Gross ET, Han S, Vemu P, Peinado CD, Marsala M, Ellies L, Bui JD. Immunosurveillance and immunoediting of MMTV-PyMT-induced mammary oncogenesis. Oncoimmunology 2016 Dec 14;6(2).
  5. Chen YB, Efebera YA, Johnston L, Ball ED, Avigan D, Lekakis LJ, Bachier CR, Martin P, Duramad O, Ishii Y, Han S, Jung Y, Lee D, Kunkel L, Negrin RS, Bui JD. Increased Foxp3+Helios+ regulatory T cells and decreased acute graft-versus-host disease after allogeneic bone marrow transplantation in patients receiving sirolimus and RGI-2001, an activator of invariant natural killer T cells. Biol Blood Marrow Transplant. 2017 Apr;23(4):625-634.
  6. Seelige R, Washington Jr A, Bui JD. The ancient cytokine IL-17D is regulated by Nrf2 and mediates tumor and virus surveillance. Cytokine 2017 Mar;91:10-12.
  7. Seelige R, Searles, S, Bui JD. Innate sensing of cancer’s non-immunologic hallmarks. Curr Opinion in Immunology 2017 Oct 12;50:1-8.
  8. Meier A, Gross ETE, Schilling JM, Seelige R, Jung Y, Santosa E, Searles S, Lin T, Tu XM, Patel HH, Bui JD. Isoflurane Impacts Murine Melanoma Growth in a Sex-Specific, Immune-Dependent Manner: A Brief Report. Anesth Analg. 2018 Mar 21.
  9. Seelige R, Saddawi-Konefka R, Adams NM, Picarda G, Sun JC, Benedict CA, Bui JD. Interleukin-17D and Nrf2 mediate initial innate immune cell recruitment and restrict MCMV infection. Sci Rep. 2018 Sep 12;8(1):13670.
  10. Fong JJ, Tsai CM, Saha S, Nizet V, Varki A*, Bui JD*. Siglec-7 engagement by GBS β-protein suppresses pyroptotic cell death of natural killer cells. Proc Natl Acad Sci U S A. 2018 Oct 9;115(41):10410-10415.
  11. Gross ETE, Peinado CD, Jung Y, Han S, Liu B, Santosa EK, and Bui JD. Identification and editing of stem-like cells in methylcholanthrene-induced sarcomas. OncoImmunology 2018 Oct 31;8(1).
  12. Yokoyama Y, Lew ED, Seelige R, Tindall EA, Walsh C, Fagan PC, Lee JY, Nevarez R, Oh J, Tucker KD, Chen M, Diliberto A, Vaaler H, Smith KM, Albert A, Li G*, Bui JD*. Immuno-Oncological Efficacy of RXDX-106, a Novel Small Molecule Inhibitor of the TAM (TYRO3, AXL, MER) Family of Kinases. Cancer Research 2019 Feb 5.